By Emily MacHale
May 11, 2016
Tustin, CA - Integrium Clinical Research has announced they will be attending BIO International Convention on June 6th through 9th, 2016 in San Francisco, CA. Integrium is looking forward to joining other industry leaders and pharmaceutical companies to fulfill networking goals and potential partnerships. As accomplished in previous years, Integrium will not only be forming relationships, but educating themselves on the hot topics in biotechnology and healthcare.
BIO International Convention, also known as "BIO", brings together over 15,000 biotechnology and pharmaceutical influential leaders to network and find new opportunities together. The event includes topics such as drug discovery, genomics, biomanufacturing, biofuels, nanotechnology and cell therapy.
In addition to engaging topics and discussions, BIO provides training, business development initiatives, seminars, meetings, etc., that continue the length of the four day convention. The convention is possible due to the many sponsors and attendees that are involved each year.
Through a trusted partnership with PoC Capital, Integrium is able to assist Micro Cap, Small Cap, and Privately held Biotechs looking to raise additional financing, by providing new clinical data to create the next bump in valuation. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases.
To learn more about Integrium Clinical Research, please contact:
Executive Director, Business Development
Phone: (908) 295-4578